This paper reports the bone marrow histological picture in 7 patients with hairy cell leukemia treated with recombinant interferon. Bone marrow biopsies were performed at diagnosis, after 1, 3 and 7 months from the beginning of treatment and at 12 months at treatment suspension. The main modifications observed were a conspicuous reduction of hairy cell infiltrate, profound hypoplasia induced by the drug, early evidence of focal erythropoiesis followed by the appearance of other hematopoietic series and a progressive reduction of the reticulum. The clinical response to interferon therapy was good in all the patients studied; however future studies will have to evaluate the duration of response after treatment suspension
The description of hairy cell leukemia as a specific clinical entity was published 50 years ago. The...
During the past 5 years, clinical trials in hairy cell leukemia have shown dramatic activity for alp...
We treated 13 Hairy Cell Leukemia patients with rIFN a 2b. In case of complete/partial response, the...
Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedu...
The "in vitro" effect of IFN-alpha on the phenotypic profile of atypical cells from 5 hairy cell leu...
the effect of alpha interferon on the immune has been investigated in vitro in HCL patient
Twenty-five patients with Hairy Cell Leukemia (HCL), eleven in post-splenectomy progressive disease,...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
To investigate the possible direct effects of alpha-interferon (IFN-alpha) in hairy cell leukemia, I...
Evaluation of the histologic changes of the bone marrow and clinical data of 12 male and 2 female pa...
To further define the mechanisms responsible for the alpha-interferon (alpha-IFN) efficacy in the tr...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
Hairy cell leukemia (HCL), a well-recognized chronic lymphoproliferative disorder, is frequently cha...
Eighty nine of 104 patients with hairy cell leukemia (HCL), enrolled between 1985 and 1987 in a mult...
Hairy cells (HCs), derived from the peripheral blood and spleen of hairy cell leukemia (HCL) patient...
The description of hairy cell leukemia as a specific clinical entity was published 50 years ago. The...
During the past 5 years, clinical trials in hairy cell leukemia have shown dramatic activity for alp...
We treated 13 Hairy Cell Leukemia patients with rIFN a 2b. In case of complete/partial response, the...
Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedu...
The "in vitro" effect of IFN-alpha on the phenotypic profile of atypical cells from 5 hairy cell leu...
the effect of alpha interferon on the immune has been investigated in vitro in HCL patient
Twenty-five patients with Hairy Cell Leukemia (HCL), eleven in post-splenectomy progressive disease,...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
To investigate the possible direct effects of alpha-interferon (IFN-alpha) in hairy cell leukemia, I...
Evaluation of the histologic changes of the bone marrow and clinical data of 12 male and 2 female pa...
To further define the mechanisms responsible for the alpha-interferon (alpha-IFN) efficacy in the tr...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
Hairy cell leukemia (HCL), a well-recognized chronic lymphoproliferative disorder, is frequently cha...
Eighty nine of 104 patients with hairy cell leukemia (HCL), enrolled between 1985 and 1987 in a mult...
Hairy cells (HCs), derived from the peripheral blood and spleen of hairy cell leukemia (HCL) patient...
The description of hairy cell leukemia as a specific clinical entity was published 50 years ago. The...
During the past 5 years, clinical trials in hairy cell leukemia have shown dramatic activity for alp...
We treated 13 Hairy Cell Leukemia patients with rIFN a 2b. In case of complete/partial response, the...